Oncobiologics, Inc. (ONS): Stock Offering News

Jan 2, 2018

Get Free Updates

Key Facts Surrounding This News Item

ONS had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Oncobiologics, Inc. (ONS)

Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology. The company was founded in 2010 and is based in Cranbury, New Jersey. View our full ONS ticker page with ratings, news, and more.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

3 Investment Lessons Learned in 2019

SPY is up 25% year to date. That we know. Now let's discuss 3 additional lessons learned this year and how it will help us chart a course to greater investment success in 2020.

Dec 6, 2019 | 3:54pm

: ogi | Organigram Holdings Inc. News, Ratings, and Charts

Does OrganiGram’s (OGI) New Equity Program Mean it’s Time to Buy the Stock?

This week, OrganiGram Holdings Inc. (OGI) announced it had established an At-The-Market equity program allowing the company to issue up to C$55,000,000 of common shares from its treasury to the public

Dec 6, 2019 | 1:51pm

NYSE: DIS | Walt Disney Company (The) News, Ratings, and Charts

Why I’m Bearish On Disney (DIS) in the Short-term

I know being bearish on Disney (DIS) might cast me as a villain but I have to got to call it like I see it. And I think it’s stock is due for a pullback and I will be employing a limited risk option strategy.

Dec 6, 2019 | 12:59pm

Market Commentary: I Normally Love Sausage, But This is Crazy

It will be hard for stocks (SPY) to make it to new highs without the China trade deal being finalize. But that doesn't mean to run away from the market either. Read on for more.

Dec 5, 2019 | 12:23pm

: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Has Marijuana Stock HEXO Corp. (HEXO) Found a Bottom?

This past month HEXO has shown stability, holding onto $2 per share, and many investors are speculating that this could be the bottom.

Dec 5, 2019 | 12:03pm

More Oncobiologics, Inc. (ONS) News View All

Event/Date	Symbol	News Detail	Start Price	End Price	Change	POWR Rating
Loading, please wait...

View All ONS News